Analyst Reco. Moderna, Inc.

Equities

MRNA

US60770K1079

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-14 pm EDT			5-day change	1st Jan Change
128.3 ^USD	+2.11%		+5.99%	+29.03%

May. 14	Investors need more than PPI to make up their minds
May. 14	ANALYST RECOMMENDATIONS : Nike, Roblox, Starbucks, Walmart, Deckers Outdoor...

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ANALYST RECOMMENDATIONS : Nike, Roblox, Starbucks, Walmart, Deckers Outdoor...	May. 14
Evercore ISI Initiates Moderna With In Line Rating, $120 Price Target	May. 14	MT
Moderna Insider Sold Shares Worth $1,825,220, According to a Recent SEC Filing	May. 13	MT
Deutsche Bank Raises Moderna's Price Target to $85 From $70	May. 09	MT
UBS Adjusts Moderna Price Target to $151 From $143, Maintains Buy Rating	May. 07	MT
News Highlights : Top Financial Services News of the Day - Monday at 11 AM ET	May. 06	DJ
Moderna Insider Sold Shares Worth $1,663,855, According to a Recent SEC Filing	May. 06	MT
Jefferies Adjusts Price Target on Moderna to $155 From $125	May. 03	MT
Oppenheimer Adjusts Price Target on Moderna to $163 From $142	May. 03	MT
Goldman Sachs Adjusts Price Target on Moderna to $204 From $206	May. 03	MT
Leerink Adjusts Price Target on Moderna to $60 From $59	May. 03	MT
Morgan Stanley Adjusts Price Target on Moderna to $95 From $89	May. 03	MT
Jefferies & Co Adjusts Moderna Price Target to $155 From $125	May. 03	MT
Goldman Sachs Adjusts Moderna Price Target to $204 From $206	May. 03	MT
Morgan Stanley Raises Price Target on Moderna to $95 From $89, Keeps Equalweight Rating	May. 03	MT
RBC Raises Price Target on Moderna to $135 From $125 on 'More Prudent Financial Outlook,' Keeps Outperform Rating	May. 03	MT
ANALYST RECOMMENDATIONS : Alphabet, Amgen, Starbucks, PayPal, Moderna...	May. 03
MODERNA : price target raised by Oddo BHF	May. 03	CF
RBC Raises Price Target on Moderna to $135 From $125	May. 02	MT
Chardan Research Lowers Metagenomi's PT to $17 From $21 on Heels of Announced Termination of Collaboration With Moderna, Keeps Buy Rating	May. 02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Moderna, Inc. prepares for the post-Covid era

March 25, 2024 at 10:24 am EDT

Stéphane Bancel, CEO of Moderna: Restoring confidence in the vaccines sector

January 16, 2024 at 03:31 pm EST